Inventor · disambiguated record
Peter Moldt
Also filed as: MOLDT PETER
24 granted patents·3 pending applications·327 citations·filing 1990–2008
96Inventor score
Top patents by PatentIndex Score
27 records- 0185US5444070APhenyl substituted heterocyclic compoundsNEUROSEARCH AS·Filed 1993·Granted Aug 22, 1995·70 cites·9 claims
- 0283US5696138AUrea derivatives and their useNEUROSEARCH AS·Filed 1994·Granted Dec 9, 1997·58 cites·8 claims
- 0377US5554626ASubstituted heterocyclic compounds as dopamine-reuptake inhibitorsNEUROSEARCH AS·Filed 1993·Granted Sep 10, 1996·24 cites·9 claims
- 0476US6288079B1Tropane-derivatives, their preparation and useNEUROSEARCH AS·Filed 1997·Granted Sep 11, 2001·30 cites·15 claims
- 0573US6395748B2Tropane-derivatives, their preparation and useNEUROSEARCH AS·Filed 2001·Granted May 28, 2002·5 cites·7 claims
- 0672US5210091AImidazole compounds and their useNEUROSEARCH AS·Filed 1992·Granted May 11, 1993·13 cites·10 claims
- 0770US5374636A2,3-trans-disubstituted tropane compounds which have useful pharmaceutical utilityNEUROSEARCH AS·Filed 1993·Granted Dec 20, 1994·32 cites·9 claims
- 0869US8263611B2Hydrochloride salt of an azabicyclo[3.2.1]octane derivativeGRINTER TREVOR JOHN·Filed 2008·Granted Sep 11, 2012·2 cites·14 claims
- 0965US5225604AHydroxycarbonyl derivatives and process for making the sameNEUROSEARCH AS·Filed 1991·Granted Jul 6, 1993·8 cites·3 claims
- 1063US5097063AHydroxycarbonyl derivatives and process for making the sameNEUROSEARCH AS·Filed 1990·Granted Mar 17, 1992·9 cites·25 claims
- 1160US5736556ATropane-2-aldoxime derivatives as nevro transmitter reuptake inhibitorsNEUROSEARCH AS·Filed 1995·Granted Apr 7, 1998·17 cites·22 claims
- 1252US5296493A1-substituted-2-(N-phenyl-N-(phenylmethyl)methanamine)-4,5-dihydro-imidazoles and related compounds and their use in treating calcium overload in brain cellsNEUROSEARCH AS·Filed 1991·Granted Mar 22, 1994·4 cites·17 claims
- 1351US5917053AIndole-2,3-dione-3-oxime derivatives, their preparation and useNEUROSEARCH AS·Filed 1995·Granted Jun 29, 1999·9 cites·23 claims
- 1451US5369113ACertain 2,3-diphenyl-2-(1,2,4-oxadiazol-5-yl)tropanes useful as dopamide reuptake inhibitorsNEUROSEARCH AS·Filed 1993·Granted Nov 29, 1994·12 cites·9 claims
- 1550US5801174AFused indole and quinoxaline derivatives, their preparation and useNEUROSEARCH AS·Filed 1995·Granted Sep 1, 1998·9 cites·14 claims
- 1650US2002128284A1Tropane-derivatives, their preparation and useNEUROSEARCH AS·Filed 2002·Application pending·0 cites
- 1747US2009214597A1Non-injection immunotherapyCURALOGIC AS·Filed 2006·Application pending·0 cites
- 1845US2006269576A1Non-injection immunotherapyCURALOGIC AS·Filed 2005·Application pending·0 cites
- 1944US5314903ABenzimidazole compounds useful as calcium channel blockersNEUROSEARCH AS·Filed 1992·Granted May 24, 1994·5 cites·7 claims
- 2044US5158969AIndole derivatives as potassium channel blockersNEUROSEARCH AS·Filed 1991·Granted Oct 27, 1992·10 cites·8 claims
- 2141US6180649B11-(4-piperidyl)-benzimidazoles having neurotrophic activityNEROSEARCH AS·Filed 1997·Granted Jan 30, 2001·3 cites·10 claims
- 2238US6100275A8-azabicyclo[3.2.1.]oct-2-ene derivatives, their preparation and useNEUROSEARCH AS·Filed 1996·Granted Aug 8, 2000·3 cites·9 claims
- 2338US5166441AAstaxanthin intermediatesNEUROSEARCH AS·Filed 1991·Granted Nov 24, 1992·1 cites·2 claims
- 2437US6376673B1Piperidine derivatives as neurotransmitter re-uptake inhibitorsNEUROSEARCH AS·Filed 1999·Granted Apr 23, 2002·2 cites·7 claims
- 2534US5475015ABenzimidazole derivatives, their preparation and pharmaceutical useNEUROSEARCH AS·Filed 1994·Granted Dec 12, 1995·1 cites·8 claims
- 2632US5107010AAstaxanthin intermediatesNEUROSEARCH AS·Filed 1990·Granted Apr 21, 1992·0 cites·2 claims
- 2731US5990312AMethod for the preparation of esters of anhydroecgonineNEUROSEARCH AS·Filed 1996·Granted Nov 23, 1999·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Peter Moldt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →